Decreased thyroid follicle size in dwarf mice may suggest the role of growth hormone signaling in thyroid growth regulation

Thyroid Research

Volumn 5, Issue 1, 2012, Pages

  Gesing, Adam ^a,b   Bartke, Andrzej ^b   Masternak, Michal M ^c,d   Lewiski, Andrzej ^a,e   Karbownik Lewiska, Magorzata ^a,e  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^d INSTITUTE OF HUMAN GENETICS   (Poland)

^e POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Ames dwarf mice; Follicular epithelium thickness; GHRKO mice; Inner follicular perimeter; Inner follicular surface area; Thyroid follicle

Indexed keywords

EID: 84867172577     PISSN: None     EISSN: 17566614     Source Type: Journal    
DOI: 10.1186/1756-6614-5-7     Document Type: Article

References (48)

1. Thyroid growth-stimulating and growth-inhibiting factors. Lewiski A, Pawlikowski M, Cardinali DP, Biol Signals 1993 2 313 351 10.1159/000109512 7913649
2. Morphogenesis of the thyroid gland. Fagman H, Nilsson M, Mol Cell Endocrinol 2010 323 35 54 10.1016/j.mce.2009.12.008 20026174
3. Molecules important for thyroid hormone synthesis and action - known facts and future perspectives. Brix K, Führer D, Biebermann H, Thyroid Res 2011 4 Suppl 1 9 10.1186/1756-6614-4-S1-S9 21835056
4. Minireview: Intrinsic and extrinsic factors in thyroid gland development: an update. De Felice M, Di Lauro R, Endocrinology 2011 152 2948 2956 10.1210/en.2011-0204 21693675
5. Influence of dietary iodine deficiency on the thyroid gland in Slc26a4-null mutant mice. Iwata T, Yoshida T, Teranishi M, Murata Y, Hayashi Y, Kanou Y, Griffith AJ, Nakashima T, Thyroid Res 2011 4 10 10.1186/1756-6614-4-10 21689387
6. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Coalo AM, Lombardi G, Baldelli R, Camanni F, Liuzzi A, Acromegaly Study Group of the Italian Society of Endocrinology, J Endocrinol Invest 2002 25 240 245 11936466
7. Thyroid cancer is the most common cancer associated with acromegaly. Gullu BE, Celik O, Gazioglu N, Kadioglu P, Pituitary 2010 13 242 248 10.1007/s11102-010-0224-9 20217483
8. Thyroid cancer in patients with acromegaly: a case-control study. Dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R Jr, Vilar L, Albano MF, Alves AR, Parente CV, Dos Santos Faria M, Pituitary 2012 in press, http://dx.doi.org/ 10.1007/s11102-012-0383-y
9. Can growth hormone (GH) accelerate aging ? Evidence from GH transgenic mice. Bartke A, Neuroendocrinology 2003 78 210 216 10.1159/000073704 14583653
10. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, OConnell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG, Nature 1996 384 327 333 10.1038/384327a0 8934515
11. Dwarf mice and the ageing process. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A, Nature 1996 384 33 8900273
12. Genes that prolong life: relationships of growth hormone and growth to aging and life span. Bartke A, Coschigano K, Kopchick J, Chandrashekar V, Mattison J, Kinney B, Hauck S, J Gerontol A Biol Sci Med Sci 2001 56 340 B349 10.1093/gerona/56.8.B340 11487592
13. Life extension in the dwarf mouse. Bartke A, Brown-Borg H, Curr Top Dev Biol 2004 63 189 225 15536017
14. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. Dominici FP, Hauck SJ, Argentino DP, Bartke A, Turyn D, J Endocrinol 2002 173 81 94 10.1677/joe.0.1730081 11927387
15. Low body temperature in long-lived Ames dwarf mice at rest and during stress. Hunter WS, Croson WB, Bartke A, Gentry MV, Meliska CJ, Physiol Behav 1999 67 433 437 10.1016/S0031-9384(99)00098-0 10497963
16. Expression of oxidative phosphorylation components in mitochondria of long-living Ames dwarf mice. Brown-Borg HM, Johnson WT, Rakoczy SG, Age (Dordr) 2012 34 43 57 10.1007/s11357-011-9212-x
17. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigano K, Wagner TE, Baumann G, Kopchick JJ, Proc Natl Acad Sci USA 1997 94 13215 13220 10.1073/pnas.94.24.13215 9371826
18. Is the Laron mouse an accurate model of Laron syndrome ? Kopchick JJ, Laron Z, Mol Genet Metab 1999 68 232 236 10.1006/mgme.1999.2890 10527674
19. Assessment of growth parameters and life span of GHR/BP gene disrupted mice. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ, Endocrinology 2000 141 2608 2613 10.1210/en.141.7.2608 10875265
20. Consequences of growth hormone (GH) overexpression and GH resistance. Bartke A, Chandrashekar V, Bailey B, Zaczek D, Turyn D, Neuropeptides 2002 36 201 208 10.1054/npep.2002.0889 12359510
21. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased lifespan. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ, Endocrinology 2003 144 3799 3810 10.1210/en.2003-0374 12933651
22. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Liu JL, Coschigano KT, Robertson K, Lipsett M, Guo Y, Kopchick JJ, Kumar U, Liu YL, Am J Physiol Endocrinol Metab 2004 287 405 E413 10.1152/ajpendo.00423.2003 15138153
23. Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. Salmon AB, Murakami S, Bartke A, Kopchick J, Yasumura K, Miller RA, Am J Physiol Endocrinol Metab 2005 289 23 E29 10.1152/ajpendo.00575.2004 15701676
24. Aging-related characteristics of growth hormone receptor/binding protein gene-disrupted mice. Coschigano KT, Age (Dordr) 2006 28 191 200 10.1007/s11357-006-9004-x
25. Stress resistance and aging: Influence of genes and nutrition. Harper JM, Salmon AB, Chang Y, Bonkowski M, Bartke A, Miller RA, Mech Ageing Dev 2006 127 687 694 10.1016/j.mad.2006.04.002 16713617
26. Fibroblasts from long-lived mutant mice show diminished ERK1/2 phosphorylation but exaggerated induction of immediate early genes. Sun LY, Steinbaugh MJ, Masternak MM, Bartke A, Miller RA, Free Radic Biol Med 2009 47 1753 1761 10.1016/j.freeradbiomed.2009.09.021 19786089
27. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. Ikeno Y, Hubbard GB, Lee S, Cortez LA, Lew CM, Webb CR, Berryman DE, List EO, Kopchick JJ, Bartke A, J Gerontol A Biol Sci Med Sci 2009 64 522 529 19228785
28. Renal pro-apoptotic proteins are reduced by growth hormone resistance but not by visceral fat removal. Gesing A, Bartke A, Wang F, Karbownik-Lewiska M, Masternak MM, Biol Chem 2011 392 475 481 21391871
29. Decreased expression level of apoptosis-related genes and/or proteins in skeletal muscles, but not in hearts, of growth hormone receptor knockout mice. Gesing A, Masternak MM, Wang F, Lewiski A, Karbownik-Lewiska M, Bartke A, Exp Biol Med 2011 236 156 168 10.1258/ebm.2010.010202
30. Deletion of growth hormone receptor gene but not visceral fat removal decreases expression of apoptosis-related genes in the kidney - potential mechanism of lifespan extension. Gesing A, Masternak MM, Wang F, Karbownik-Lewiska M, Bartke A, Age (Dordr) 2012 34 295 304 10.1007/s11357-011- 9232-6
31. Key regulators of mitochondrial biogenesis are increased in kidneys of growth hormone receptor knockout (GHRKO) mice. Gesing A, Bartke A, Wang F, Karbownik-Lewiska M, Masternak MM, Cell Biochem Funct 2011 29 459 467 10.1002/cbf.1773 21755522
32. Expression of key regulators of mitochondrial biogenesis in growth hormone receptor knockout (GHRKO) mice is enhanced but is not further improved by other potential life extending interventions. Gesing A, Masternak MM, Wang F, Joseph A-M, Leeuwenburgh C, Westbrook R, Lewiski A, Karbownik-Lewiska M, Bartke A, J Gerontol A Biol Sci Med Sci 2011 66 1062 1076 21788651
33. Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A, Exp Biol Med 2001 226 552 558
34. Alterations in oxygen consumption, respiratory quotient, and heat production in long-lived GHRKO and Ames dwarf mice, and short-lived bGH transgenic mice. Westbrook R, Bonkowski MS, Strader AD, Bartke A, J Gerontol A Biol Sci Med Sci 2009 64 443 451 19286975
35. Gender-specific regulation of response to thyroid hormone in aging. Suzuki S, Nishio S, Takeda T, Komatsu M, Thyroid Res 2012 5 1 10.1186/1756-6614-5-1 22280879
36. Effects of combined growth hormone deficiency and resistance in double-mutant Ames dwarf/GHR-KO mice [abstract]. Masternak MM, Wang F, Spong A, Gesing A, Bartke A, Exp Gerontol 2011 46 212 213
37. Histology of the anterior hypophysis, thyroid and gonads of two types of dwarf mice. Bartke A, Anat Rec 1964 149 225 235 10.1002/ar.1091490206 14173795
38. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Li S, Crenshaw EB 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG, Nature 1990 347 528 533 10.1038/347528a0 1977085
39. Thyroid gland in dwarf mice. Cordier AC, Denef JF, Haumont SM, Cell Tissue Res 1976 171 449 457 975224
40. Effects of insulin-like growth factor I, epidermal growth factor and kalium iodide on thymidine kinase activity in homogenates of rat thyroid lobes incubated in vitro. Brzeziski J, Lewiski A, Karbownik M, Gesing A, Modrzejewska H, Greger J, Biomed Lett 1997 55 153 167
41. Expression of insulin-like growth factor I (IGF-I) gene and of genes for IGF-binding proteins 1, 2, 3, 4 (IGFBP-1-IGFBP-4) in non-neoplastic human thyroid cells and in certain human thyroid cancers. Effect of exogenous IGF-I on this expression. Lewiski A, Marcinkowska M, Brzeziaska E, Jeziorowska A, Woch J, Brzeziski J, Endocr Res 2004 30 47 59 10.1081/ERC-120028484 15098919
42. Increased lipid peroxidation in growth hormone-deficient adult patients. Kokoszko A, Karbownik M, Lewiski A, Neuroendocrinol Lett 2006 27 225 230 16648797
43. GH replacement reduces increased lipid peroxidation in GH-deficient adults. Karbownik-Lewiska M, Kokoszko A, Lewandowski KC, Shalet SM, Lewiski A, Clin Endocrinol (Oxf) 2008 68 957 964 10.1111/j.1365-2265.2007.03142.x
44. Effects of growth hormone and insulin-like growth factor-I on the iron-induced lipid peroxidation in the rat liver and porcine thyroid homogenates. Kokoszko A, Dbrowski J, Lewiski A, Karbownik-Lewiska M, Neuroendocrinol Lett 2010 31 517 523 20802456
45. Protective effects of GH and IGF-I against iron-induced lipid peroxidation in vivo. Kokoszko A, Dbrowski J, Lewiski A, Karbownik-Lewiska M, Exp Toxicol Pathol 2008 60 453 458 10.1016/j.etp.2008.04.012 18585019
46. The role of oxidative stress in physiological and pathological processes in the thyroid gland; possible involvement in pineal-thyroid interactions. Karbownik M, Lewiski A, Neuroendocrinol Lett 2003 24 293 303 14647000
47. Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications. Smyczyska J, Hilczer M, Stawerska R, Lewiski A, Thyroid Res 2010 3 2 10.1186/1756-6614-3-2 20307267
48. Do IGF-I concentrations better reflect growth hormone (GH) action in children with short stature than the results of GH stimulating tests ? Evidence from the simultaneous assessment of thyroid function. Smyczyska J, Stawerska R, Lewiski A, Hilczer M, Thyroid Res 2011 4 6 10.1186/1756-6614-4-6 21232100